McKesson Corp (J&J) has reduced its Q3 profits from 4bn $4.8bn to $ , following a recent proposed $ $4.8bn to $ opioid settlement payment. J&J, which is facing thousands of lawsuits over a variety of products, lowered its reported profit to US$1.8 billion, or 66 cents per share, from US$4.8 billion, or US$1.81 per share, and said there was no impact to its adjusted earnings numbers. J&J said it did not know when the settlement would be finalised, but would make any necessary accounting adjustments after the fact. Around thousands US lawsuits are outstanding against drug companies in relation to the opioid crisis.
McKesson Corp (J&J) has reduced its Q3 profits from 4bn $4.8bn to $ , following a recent proposed $ $4.8bn to $ opioid settlement payment. J&J said it did not know when the settlement would be finalised, but would make any necessary accounting adjustments after the fact. Around thousands US lawsuits are outstanding against drug companies in relation to the opioid crisis.